256 related articles for article (PubMed ID: 30136248)
1. The cutting-edge technologies of siRNA delivery and their application in clinical trials.
Lee K; Jang B; Lee YR; Suh EY; Yoo JS; Lee MJ; Lee JY; Lee H
Arch Pharm Res; 2018 Sep; 41(9):867-874. PubMed ID: 30136248
[TBL] [Abstract][Full Text] [Related]
2. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
[TBL] [Abstract][Full Text] [Related]
3. Journey of siRNA: Clinical Developments and Targeted Delivery.
Nikam RR; Gore KR
Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-based delivery system for application of siRNA in vivo.
Wang Y; Li Z; Han Y; Liang LH; Ji A
Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
[TBL] [Abstract][Full Text] [Related]
5. siRNA delivery systems for cancer treatment.
Oh YK; Park TG
Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles for short interfering RNA delivery.
Leung AK; Tam YY; Cullis PR
Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
[TBL] [Abstract][Full Text] [Related]
7. Systemic delivery of siRNA: challenging but promising.
Wang C; Zhou Q
Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):19-30. PubMed ID: 22188477
[TBL] [Abstract][Full Text] [Related]
8. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.
Dorrani M; Garbuzenko OB; Minko T; Michniak-Kohn B
J Control Release; 2016 Apr; 228():150-158. PubMed ID: 26965957
[TBL] [Abstract][Full Text] [Related]
9. siRNA therapeutics: a clinical reality.
Saw PE; Song EW
Sci China Life Sci; 2020 Apr; 63(4):485-500. PubMed ID: 31054052
[TBL] [Abstract][Full Text] [Related]
10. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of the systemic delivery of small interfering RNA.
Ifediba MA; Moore A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):428-37. PubMed ID: 22228711
[TBL] [Abstract][Full Text] [Related]
12. The growth of siRNA-based therapeutics: Updated clinical studies.
Zhang MM; Bahal R; Rasmussen TP; Manautou JE; Zhong XB
Biochem Pharmacol; 2021 Jul; 189():114432. PubMed ID: 33513339
[TBL] [Abstract][Full Text] [Related]
13. siRNA therapeutics in the treatment of diseases.
Bakhtiyari S; Haghani K; Basati G; Karimfar MH
Ther Deliv; 2013 Jan; 4(1):45-57. PubMed ID: 23323780
[TBL] [Abstract][Full Text] [Related]
14. Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility.
Kulkarni JA; Cullis PR; van der Meel R
Nucleic Acid Ther; 2018 Jun; 28(3):146-157. PubMed ID: 29683383
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.
Chaturvedi K; Ganguly K; Kulkarni AR; Kulkarni VH; Nadagouda MN; Rudzinski WE; Aminabhavi TM
Expert Opin Drug Deliv; 2011 Nov; 8(11):1455-68. PubMed ID: 21867463
[TBL] [Abstract][Full Text] [Related]
16. RNAi therapeutics: an update on delivery.
Nguyen T; Menocal EM; Harborth J; Fruehauf JH
Curr Opin Mol Ther; 2008 Apr; 10(2):158-67. PubMed ID: 18386228
[TBL] [Abstract][Full Text] [Related]
17. Delivering silence: advancements in developing siRNA therapeutics.
Novobrantseva TI; Akinc A; Borodovsky A; de Fougerolles A
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):217-24. PubMed ID: 18283609
[TBL] [Abstract][Full Text] [Related]
18. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
19. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
Springer AD; Dowdy SF
Nucleic Acid Ther; 2018 Jun; 28(3):109-118. PubMed ID: 29792572
[TBL] [Abstract][Full Text] [Related]
20. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
DeVincenzo JP
Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
